The Global DNA Vaccines Market is valued at USD 2.38 Billion in 2020 and is expected to reach USD 10.95 Billion by 2027 with a CAGR of 24.4% over the forecast period.
Scope of Global DNA Vaccines Market Analysis Report
The technique of injecting a specific antigen DNA-coding sequence by which cells directly produce an antigen, resulting in a protective immunological response against disease is known as DNA vaccination. These vaccine codes are for antigen-specific proteins. DNA vaccines are majorly used for veterinary use and there has been promising research using the vaccines for viral, bacterial and parasitic diseases, as well as to several types of tumors. DNA vaccine is also known as a third-generation vaccine. Rabies virus, lymphocytic choriomeningitis virus, malarial parasites and mycoplasmas, Hepatitis B virus, influenza virus, HIV virus are infectious agents used for obtaining genes. The immune response focused on the antigen of interest, DNA vaccines are cost-effective and there is less risk for infection. In DNA vaccines antigen presentation by MHC class I and class II molecules, long-term persistence of immunogen. DNA vaccines are more stable, cost-efficient, easy to manufacture and safe in handling and used therapy for cancer, allergies, autoimmune diseases and infectious disease.
Request Sample PDF @ https://brandessenceresearch.com/requestSample/PostId/1803?Med_Guru
Some of the key players/Manufacturers involved in the DNA Vaccines Market are:
- Novartis Ag
- Pfizer Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Merck & Co.
- Gilead Sciences Inc.
- Sanofi-Aventis
- Johnson & Johnson
- others
Global DNA Vaccines Market Segmentation Analysis:
By Type:
- Human DNA Vaccines
- Animal DNA Vaccines
By Technology:
- pDNA Vaccines Technology
- pDNA Delivery Technology
By Application:
- Human Diseases
- Veterinary Diseases
- Allergies
- Others
By End-User:
- Human Health
- Animal Health
- Research Application
By Therapeutic Indications:
- Vector-Borne Disease
- Cancer
News: India first to developed DNA vaccine, can be administered to 12 and above
25th September 2021; First DNA vaccines against COVID-19, which can be administered to all people above the age of 12 years had announced by Prime Minister Narendra Modi. The vaccine will be given to kids between age group of 12-18 in the country. The vaccine development and manufacturing with limited resources is under India’s The Sewa Paramo Dharma Campaign. The needle free COVID-19 vaccine, ZyCoV-D (Zydus Cadila’s indigenously developed) permitted by Drugs Controller General of India beneath Emergency Use Authorisation (EUA).
Buy Now @ https://brandessenceresearch.com/Checkout?report_id=1803
North America Dominates the Global DNA Vaccines Market
North America dominates the global DNA vaccines market due to the increasing number of cancer patients, research & development in DNA vaccines,s and the presence of key players in this region. DNA vaccines are used for treating cancer. Thus, the adoption of DNA vaccines is fueling the growth of the market in this region. For example, according to the National Institute of Cancer, in 2020, about 1,806,590 new cases of cancer are diagnosed in the United States. In addition to that, research and development for the covid virus further accelerate the market growth. For instance, as per the news published on 9th November 2021, U.S FDA permitted phase 3 division for COVID-19 DNA vaccine to INOVIO. Moreover, the presence of key players and government investments along with increased awareness for vaccines which are constantly creating technological advancement followed by the launch of new vaccines are expected to drive the market growth.
Asia-Pacific is anticipated to be the fastest-growing regional market over the forecast period due to the increasing population and rising number of COVID-19 patients and government initiatives for research. An increasing number of COVID patients in India boosted the market growth of the global DNA vaccine in the Asia-Pacific region. For instance, according to the World Health Organization (WHO), as of 14th December 2021, there are 34,703,644 confirmed cases of COVID-19, in India. In addition to that research by key players for the development of vaccines is augmenting the market growth. For instance, Indian pharmaceutical company Zydus Cadila developed the COVID-19 DNA, it was the first DNA vaccine that received approval, and this vaccine approval represents a noteworthy step forward for DNA vaccines. Moreover, government initiatives and investment for instance, according to IBEF (Indian Brand Equity Foundation) in October 2021, US$ 100 million planned to invest by Biz2Credit, a fintech company, in India for the next five years on research and development activities and expansions. Thus, these investments are expected to drive market growth in the Asia Pacific region.
On Special Requirement DNA Vaccines Market Report is also available for below region:
North America
- S., Canada
Europe
- Germany, France, U.K., Italy, Spain, Sweden, Netherlands, Turkey, Switzerland, Belgium, Rest of Europe
Asia-Pacific
- South_Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC
Latin America
- Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America
Middle East and Africa
- Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA
Key Questions This Study Will Answer:
- What is the scope of growth in the DNA Vaccines market?
- What is the core strategy for growth in the DNA Vaccines market?
- What is the promise of growth in the long run?
- What is the promise of growth during the forecast period?
- How big is the DNA Vaccines market?
- What are the main opportunities for growth in the DNA Vaccines market?
- What are the key regions for future investments?
- What is the scope of growth in a particular country/ region of my interest?
- What are the risks involved in investing in the DNA Vaccines market?
- Who are the key players in the DNA Vaccines market?
- What are the core strategies of key players in the DNA Vaccines market?
Browse Full and Sample Report Description Along with TOC & List of Facts & Figures Here
Other Trending Reports:
- Pulmonary Function Testing Systems Market Size, Share, And Trends Analysis 2022 to 2028
- Vaccines Market
- North America Self Testing Market Size Share Companies & Trends Analysis Report & Forecasts 2022 – 2028
- Telemedicine Market
- MRNA Vaccine & Therapeutics Raw Material Market Size, Share & Trends Analysis
- Corona Virus Vaccine Market
- Healthcare Analytics Market is valued at USD 29.54 Billion in 2021 and expected to reach USD 162.69 Billion by 2028 with a CAGR of 27.6% over the forecast period.
- Live Streaming Market
I-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Follow Us: LinkedIn
Contact:
Email: vishal@brandessenceresearch.com
Email: Sales@brandessenceresearch.com
Corporate Sales: +44-2038074155
Asia Office: +917447409162